✦ LIBER ✦

Paclitaxel approved in Canada for metastatic breast cancer

Book ID: 120850263
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2006
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200615560-00062

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Approved Agents for Metastatic Breast Ca

Approved Agents for Metastatic Breast Cancer

✍ Monica N. Fornier 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 399 KB

Liposomal doxorubicin granted approval i

Liposomal doxorubicin granted approval in Canada for use in metastatic breast cancer

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Anastrozole approved in Canada for breas

Anastrozole approved in Canada for breast cancer

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Paclitaxel ± bevacizumab for metastatic

Paclitaxel ± bevacizumab for metastatic breast cancer

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Bevacizumab approval revoked for metasta

Bevacizumab approval revoked for metastatic breast cancer

✍ Elizabeth Mechcatie; Lisa LaMotto 📂 Article 📅 2011 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 48 KB

Paclitaxel plus Bevacizumab versus Pacli

Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer

✍ Miller, Kathy; Wang, Molin; Gralow, Julie; Dickler, Maura; Cobleigh, Melody; Per 📂 Article 📅 2007 🏛 Massachusetts Medical Society 🌐 English ⚖ 287 KB